Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia-Reference-Cited by-同舟云学术

Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia

Published:2019-06-04 Issue:13 Volume:60 Page:3330-3332
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dragani Matteo¹^ORCID,Rege-Cambrin Giovanna¹,Ferrero Dario²,Abruzzese Elisabetta³,Pregno Patrizia⁴,Elena Chiara⁵,Cedrone Michele⁶,Santoro Marco⁷,Andreani Giacomo¹,Saglio Giuseppe¹,Fava Carmen¹

Affiliation:

1. Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy;

2. Department of Molecular Biotechnologies and Health Sciences, Hematology Division, University of Turin, Turin, Italy;

3. Hematology Unit, S. Eugenio Hospital, Rome, Italy;

4. Department of Hematology, A.O.U Città della Salute e della Scienza di Torino, Turin, Italy;

5. Hematology Unit, University of Pavia, Pavia, Italy;

6. UOC of Hematology, San Giovanni – Addolorata Hospital, Rome, Italy;

7. Hematology Unit, University of Palermo, Palermo, Italy

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1622103

Reference13 articles.

1. Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia

2. Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

3. The concept of treatment-free remission in chronic myeloid leukemia

4. Moving treatment-free remission into mainstream clinical practice in CML

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia;PLOS ONE;2022-03-17

2. Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice;HemaSphere;2020-11-24

3. Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR;Cancers;2020-11-06

4. Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia;Case Reports in Hematology;2020-03-23

5. Prospects for achieving treatment‐free remission in chronic myeloid leukaemia;British Journal of Haematology;2020-02-14